ReviewJournal of personalized medicine2022

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases.

Giulia Gentile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.